Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)

Clinical trial NCT02622477 · COMPLETED

Trial details

NCT number: NCT02622477
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2014-06-01
Primary completion: 2016-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.